Gilgamesh Pharmaceuticals Funding: $66M Raised, Series B
Gilgamesh Pharmaceuticals is a Biotech company based in New York, NY. It has raised $66M in total funding. Latest round: Series B.
Gilgamesh Pharmaceuticals funding overview
Gilgamesh Pharmaceuticals is a Biotech company based in New York, NY. Gilgamesh Pharmaceuticals has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2022. The round record for Gilgamesh Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include Prime Movers Lab, Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund, Palo Santo Investors and 3 others. 9 distinct backers are named across the disclosed rounds.
Gilgamesh Pharmaceuticals at a glance
Total raised
$66M
Latest round
Series B
Latest round date
December 2022
Industry
Biotech
Headquarters
New York, NY
Notable investors
Prime Movers Lab, Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund, Palo Santo Investors, Alumni Ventures Group, Negev Capital
Frequently asked about Gilgamesh Pharmaceuticals funding
How much has Gilgamesh Pharmaceuticals raised?
Gilgamesh Pharmaceuticals has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Gilgamesh Pharmaceuticals?
Prime Movers Lab, Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund, Palo Santo Investors are named among the investors backing Gilgamesh Pharmaceuticals.
What was the latest Gilgamesh Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in December 2022.
Where is Gilgamesh Pharmaceuticals based?
Gilgamesh Pharmaceuticals is based in New York, NY.
What sector does Gilgamesh Pharmaceuticals operate in?
Gilgamesh Pharmaceuticals is tracked under Biotech from New York, NY, with $66M in disclosed funding.
When did Gilgamesh Pharmaceuticals last raise?
The last disclosed Gilgamesh Pharmaceuticals round closed in December 2022 at Series B.
Every Gilgamesh Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in New York at a similar stage.
